SEC Form 4 · accession 0001213900-26-085231
Tenon Medical, Inc. · TNON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Ginn
Officer — Chief Technology Officer · Director
Period of report
Jul 31, 2026
Accepted (ET)
Aug 4, 2026 · 4:42 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001560293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 31, 2026 | M | 126,577 | $0.00 | A | 212,166 | D | |
| Common StockF2 | Aug 3, 2026 | F | 44,809 | $0.198 | D | 167,357 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Jul 31, 2026 | M | 126,577 | D | — | — | Common Stock | 126,577 | 0 | D |
Explanation of responses
- F1Represents conversion of 126,577 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 126,577 shares of common stock of the Issuer on July 31, 2026.
- F2These shares were sold to pay tax liability associated with the vesting of RSUs.
- F3Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.